Want to see HK:2389 full AI Analyst Report?
Top Page
Beijing Health (Holdings) Limited
(2389)
Select Model
Select Model
Rating:49Neutral
Price Target:
HK$0.08
▲(33.33% Upside)
Action:Reiterated
Date:09/17/26
The score is held back primarily by weak financial performance—persistent large losses and mostly negative cash flow—despite the benefit of low leverage. Technicals are modestly supportive with mild positive momentum and price holding above longer-term averages, but valuation is hard to justify on earnings given the negative P/E.
Positive Factors
Low leverage
Very low leverage reduces fixed financial obligations and preserves flexibility while the company works through operational weakness. A modest debt burden can limit refinancing pressure and leave more capacity to support essential investment or restructuring over the next several quarters.
Negative Factors
Persistent large losses
Deep operating and net losses show that the current business model is not generating sufficient earnings from revenue. Continued losses can erode the equity base, restrict internal funding, and require management to make difficult decisions on costs, investment, or business structure.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage
Very low leverage reduces fixed financial obligations and preserves flexibility while the company works through operational weakness. A modest debt burden can limit refinancing pressure and leave more capacity to support essential investment or restructuring over the next several quarters.
Read all positive factors
Beijing Health (Holdings) Limited (2389) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$484.70M
Dividend YieldN/A
Average Volume (3M)569.53K
Price to Earnings (P/E)―
Beta (1Y)0.07
Revenue Growth-27.63%
EPS Growth-16.33%
CountryHK
Employees207
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-0.02
Shares Outstanding6,058,772,000
10 Day Avg. Volume644,400
30 Day Avg. Volume569,533
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)0.23
Price to Sales (P/S)2.47
P/FCF Ratio-21.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Beijing Health (Holdings) Limited Business Overview & Revenue Model
Company Description
Beijing Health (Holdings) Limited, an investment holding company, provides medical, health, and geriatric care related services and products in the People’s Republic of China. It engages in the investment and operation of general health industrial...
Beijing Health (Holdings) Limited Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
63
Positive
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 110.89M | 157.20M | 149.94M | 140.35M | 166.48M | 203.78M |
| Gross Profit | 17.21M | 42.45M | 35.68M | 38.47M | 46.51M | 46.99M |
| EBITDA | -56.82M | -77.41M | -97.47M | -44.19M | -75.25M | -10.37M |
| Net Income | -103.47M | -100.91M | -116.22M | -61.88M | -97.70M | -39.41M |
Balance Sheet | ||||||
| Total Assets | 2.05B | 2.10B | 1.95B | 2.18B | 2.42B | 2.84B |
| Cash, Cash Equivalents and Short-Term Investments | 220.43M | 237.36M | 211.08M | 335.96M | 440.76M | 496.30M |
| Total Debt | 31.70M | 114.16M | 5.65M | 4.89M | 32.75M | 48.37M |
| Total Liabilities | 294.41M | 343.11M | 209.74M | 223.82M | 271.77M | 341.34M |
| Stockholders Equity | 1.67B | 1.66B | 1.72B | 1.89B | 2.04B | 2.29B |
Cash Flow | ||||||
| Free Cash Flow | -35.90M | -18.02M | -42.20M | -45.10M | -12.34M | 406.00K |
| Operating Cash Flow | -28.10M | -5.49M | -35.56M | -43.72M | -11.19M | 1.99M |
| Investing Cash Flow | 137.06M | 154.75M | -33.80M | 74.76M | 22.77M | -227.83M |
| Financing Cash Flow | -86.66M | -88.80M | -5.28M | -68.40M | -17.71M | -20.46M |
Beijing Health (Holdings) Limited Technical Analysis
Positive
0.06
Price Trends
0.08
Negative
0.08
Positive
0.07
Positive
Market Momentum
<0.01
Positive
59.10
Neutral
80.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2389, the sentiment is Positive. The current price of 0.06 is below the 20-day moving average (MA) of 0.08, below the 50-day MA of 0.08, and below the 200-day MA of 0.07, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 59.10 is Neutral, neither overbought nor oversold. The STOCH value of 80.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2389.
Beijing Health (Holdings) Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | HK$320.38M | 9.78 | 4.28% | 8.25% | -2.78% | -24.77% | |
62 Neutral | HK$469.86M | -145.52 | -0.41% | ― | 3.16% | -101.02% | |
62 Neutral | HK$6.08B | 28.57 | 2.55% | 0.39% | 1.59% | -58.55% | |
56 Neutral | HK$1.19B | 78.10 | 0.48% | 1.10% | -3.26% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | HK$484.70M | -4.71 | -6.22% | ― | -27.63% | -16.33% |
* Healthcare Sector Average
HK:2389
Beijing Health (Holdings) Limited
0.08
>-0.01
-6.98%
HK:0286
Aidigong Maternal & Child Health
1.31
0.00
0.00%
HK:3869
Hospital Corporation of China Ltd
3.40
-3.40
-50.00%
HK:3886
Town Health International Medical Group Ltd.
0.16
-0.10
-37.40%
HK:6078
Hygeia Healthcare Holdings Co., Ltd.
9.68
-4.08
-29.65%
HK:0722
UMP Healthcare Holdings Limited
0.40
-0.07
-14.16%
Beijing Health (Holdings) Limited Corporate Events
Beijing Health Widens Interim Loss as Revenue Slumps but FX Gains Ease Overall Hit
Aug 31, 2026
Beijing Health (Holdings) Limited reported a sharp decline in revenue for the six months ended 30 June 2026, with sales falling to HK$30.3 million from HK$76.6 million a year earlier and gross profit dropping to HK$3.8 million. Higher selling and ...
Beijing Health Sets Board Meeting to Approve 2026 Interim Results and Dividend
Aug 13, 2026
Beijing Health (Holdings) Limited has scheduled a board meeting for 31 August 2026 to review and approve the group’s interim results for the six months ended 30 June 2026. The board will also consider the declaration of an interim dividend a...
Beijing Health (Holdings) strengthens board with seasoned finance executive
Jul 31, 2026
Beijing Health (Holdings) Limited has appointed Ms. Qi Man Rong as an executive director with effect from 31 July 2026, further strengthening its finance-focused leadership bench. Ms. Qi brings 19 years of experience in auditing, financial managem...
Beijing Health Clarifies Board Composition and Governance Committees
Jul 31, 2026
Beijing Health (Holdings) Limited has disclosed the current composition of its board of directors, confirming a structure of five executive directors and four independent non-executive directors under the chairmanship of Zhu Shi Xing and CEO leade...
Beijing Health Issues Profit Warning as Medical and Elderly Care Segment Swings to Loss
Jul 24, 2026
Beijing Health (Holdings) Limited has warned that its medical and elderly care products sales segment will swing from a profit to a loss for the six months ended 30 June 2026, as revenue fell about 70% year-on-year to roughly RMB19.5 million. The ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.